查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511894

mRNA合成原料的市场规模、份额和趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2024-2030年

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

mRNA 合成原料市场的成长与趋势：

Grand View Research最新报告显示，到2030年，全球mRNA合成原料市场规模预计将达到19.9亿美元。

预计2024年至2030年该市场将以2.85%的复合年增长率扩张。推动市场成长的主要因素包括学术界和工业界对 mRNA 技术兴趣的增加、mRNA 疫苗的优越性以及研究经费的增加。此外，预计在预测期内，RNA 技术的治疗应用不断增加将为 mRNA 合成市场的原料提供利润丰厚的机会。

COVID-19大流行增加了对mRNA合成原料的需求，以开发有效的疫苗来对抗感染疾病。 mRNA 疫苗是预防 COVID-19 的安全有效的方法。此外，与mRNA COVID-19疫苗相关的好处引起了製药公司的关注，以在全球范围内快速供应疫苗。例如，美国国家过敏和感染疾病研究所与Moderna, Inc.于2020年3月共同开发了mRNA-1273（NIAID）。因此，在 COVID-19 大流行期间，mRNA 疫苗的使用量显着增加。

此外，许多主要製药公司已经开始研究以 mRNA 为基础的疗法，包括诺华、亚力兄、阿斯特捷利康、辉瑞、赛诺菲巴斯德和夏尔。例如，2022年1月，根据辉瑞与Acquitas Therapeutics之间的开发和选择协议，辉瑞将针对多达10个标靶使用Acquitas的LNP技术来开发mRNA疗法和疫苗，并有权选择许可。因此，製药和生物技术公司对mRNA合成原料的采用率正在增加，这进一步推动了市场的成长。

此外，由于mRNA转译的瞬时性以及外来物质不会整合到细胞基因组中，所得的细胞疗法产品比使用更传统方法获得的产品具有许多优势。它的一些优点包括易于在公认的製造程序下製造、减少由于目标和期外效应而导致的细胞毒性，以及易于临床验证和监管处理，这包括可以改进的方面。因此，这些优势预计将增加对 mRNA 疗法的需求并进一步推动市场成长。

此外，基于 mRNA 的技术也被证明在治疗和预防多种疾病方面非常有前景。过去十年技术和科学研究的突破性进展使 mRNA 成为一种可行的治疗选择，消除了与其使用相关的一些问题，例如半衰期短和免疫抗原性。例如，mRNA 技术的进步可能会带来更安全、更有效的方法，例如与新的过继性免疫疗法相结合，创建最先进的嵌合体抗原受体 T 细胞。因此，mRNA 技术的进步预计将为市场成长开闢新的途径。

然而，在研究期间，原材料的高成本可能会拖累市场。例如，CleanCap AG等原料的采购价格约占两种疫苗生产过程中产生的原物料总成本的45%左右。此外，围绕核准流程的法律规范一直是生物技术、製药和医疗技术行业最重要的阻碍因素。中国和印度等新兴国家的 mRNA 合成原料市场具有巨大的成长潜力，由于存在庞大的患者基础，且目前尚无有效的法律规范或指南，因此预计未来几年将出现增长。受到阻碍。

mRNA合成市场原料报告要点

  • 由于封端技术及其在生物製药工业和研究中的应用的进步，封端剂细分市场在2023年占据最大份额，为39.17%。
  • 从应用来看，疫苗製造业在全球产业中占据主导地位，2023年销售份额最大。这是因为与利用以细胞培养为基础的生产途径的传统疫苗相比，mRNA 疫苗的生产速度更快，而传统疫苗往往容易失败。
  • 预计北美地区将在 2023 年主导全球产业，占总收益的最大份额，超过 36.77%，并在预测期内以最高的复合年增长率成长。
  • 由于生物製药在商业性取得了巨大成功以及治疗药物需求的快速增长，生物製药和製药公司细分市场在 2023 年以最高的收益占有率占据了市场主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 mRNA 合成原料市场：类型业务分析

  • 类型细分仪表板
  • 全球mRNA合成原料市场：类型变异分析
  • 2018-2030年全球mRNA合成原料市场规模及趋势分析（依类型）
  • 封端剂
  • 核苷酸
  • 质体DNA
  • 酵素
  • 其他的

第五章 mRNA合成原料市场：应用商业分析

  • 使用细分仪表板
  • 全球mRNA合成原料市场：应用变化分析
  • 2018年至2030年全球mRNA合成原料市场规模及趋势分析（依应用）
  • 治疗药物製造
  • 疫苗生产
  • 其他的

第六章 mRNA 合成市场原料：最终用途业务分析

  • 最终用途细分仪表板
  • 全球 mRNA 合成原料市场：最终用途变异分析
  • 2018-2030年全球mRNA合成原料市场规模及趋势分析（依最终用途）
  • 生物製药和製药公司
  • 合约研究官（CRO）和首席行销长（CMO）
  • 学术/研究机构

第 7 章 mRNA 合成原料市场：按类型、应用和最终用途分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
    • F. Hoffmann-La Roche Ltd.
    • Jena Bioscience Gmbh
    • Merck KGaA
    • Yeasen Biotechnology（Shanghai）Co.,Ltd.
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai Lifesciences
    • New England Biolabs
    • Creative Biogene
    • Hongene
Product Code: GVR-4-68040-022-4

mRNA Synthesis Raw Materials Market Growth & Trends:

The global mRNA synthesis raw materials market size is projected to reach USD 1.99 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.85% from 2024 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights:

  • The capping agents segment held the largest share of 39.17% in 2023 owing to the advancements in the capping technology and their applications in the biopharma industry and research
  • By application, The vaccine production segment dominated the global industry with the largest revenue share in 2023. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that utilize cell-culture-based production paths, which are often prone to failure.
  • North America dominated the global industry in 2023 and accounted for the largest share of more than 36.77% of the overall revenue in 2023, and is expected to grow at the highest CAGR over the forecast period.
  • The biopharmaceutical and pharmaceutical companies segment dominated the market with the highest revenue share in 2023, due to the high commercial success of biopharmaceuticals and rapid growth in demand for therapeutics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End-use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing academic and industrial interest in mRNA technology
      • 3.2.1.2. Advantages of mRNA vaccines
      • 3.2.1.3. Increasing funding for mRNA research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Nonexistence of effective government regulations for mRNA - based product approvals
      • 3.2.2.2. High cost of mRNA synthesis raw materials
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. mRNA Synthesis Raw Materials Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global mRNA Synthesis Raw Materials Market Type Movement Analysis
  • 4.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Capping Agents
    • 4.4.1. Global Capping Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Nucleotides
    • 4.5.1. Global Nucleotides Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Plasmid DNA
    • 4.6.1. Global Plasmid DNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Global Enzymes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Polymerase
      • 4.7.2.1. Global Polymerase Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. RNase Inhibitor
      • 4.7.3.1. Global RNase Inhibitor Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. DNase
      • 4.7.4.1. Global DNase Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.5. Others
      • 4.7.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. mRNA Synthesis Raw Materials Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global mRNA Synthesis Raw Materials Market Application, Movement Analysis
  • 5.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Therapeutics Production
    • 5.4.1. Global Therapeutics Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Vaccine Production
    • 5.5.1. Global Vaccine ProductionMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. mRNA Synthesis Raw Materials Market: End-use Business Analysis

  • 6.1. End-use Segment Dashboard
  • 6.2. Global mRNA Synthesis Raw Materials Market End-use Movement Analysis
  • 6.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Global Biopharmaceutical & Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Academic & Research Institutions
    • 6.6.1. Global Academic & Research Institutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. mRNA Synthesis Raw Materials Market: Regional Estimates & Trend Analysis by Type, Application, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Participant's Overview
    • 8.4.1. F. Hoffmann - La Roche Ltd.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Jena Bioscience Gmbh
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Yeasen Biotechnology (Shanghai) Co.,Ltd.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. BOC Sciences
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Thermo Fisher Scientific, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Maravai Lifesciences
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. New England Biolabs
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Creative Biogene
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Hongene
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global mRNA synthesis raw materials market, by End - use, 2018 - 2030 (USD Million)
  • Table 6 Global mRNA synthesis raw materials market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 11 U.S. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 14 Canada mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 17 Europe mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 21 UK mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 22 UK mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 23 UK mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 24 Germany mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 26 Germany mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 27 France mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 28 France mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 29 France mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 30 Italy mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 31 Italy mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 32 Italy mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 33 Spain mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 34 Spain mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 35 Spain mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 36 Denmark mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 37 Denmark mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 39 Sweden mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 40 Sweden mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 42 Norway mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 43 Norway mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 44 Norway mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 49 Japan mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 50 Japan mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 51 Japan mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 52 China mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 53 China mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 54 China mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 55 India mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 56 India mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 57 India mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 58 Australia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 59 Australia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 60 Australia mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 61 Thailand mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 62 Thailand mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 63 Thailand mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 64 South Korea mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 65 South Korea mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 66 South Korea mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 67 Latin America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 68 Latin America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 69 Latin America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 71 Brazil mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 72 Brazil mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 74 Mexico mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 75 Mexico mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 76 Mexico mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 77 Argentina mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 84 South Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 90 UAE mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait mRNA synthesis raw materials market, by end - use, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new types
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 mRNA synthesis raw materials market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 mRNA synthesis raw materials market driver analysis
  • Fig. 12 mRNA synthesis raw materials market restraint analysis
  • Fig. 13 mRNA synthesis raw materials market: Porter's analysis
  • Fig. 14 mRNA synthesis raw materials market: PESTEL analysis
  • Fig. 15 mRNA synthesis raw materials market: Type outlook and key takeaways
  • Fig. 16 mRNA synthesis raw materials market: Type market share analysis, 2023 - 2030
  • Fig. 17 Global mRNA synthesis raw materials by capping agents market, 2018 - 2030 (USD Million)
  • Fig. 18 Global mRNA synthesis raw materials by nucleotides market, 2018 - 2030 (USD Million)
  • Fig. 19 Global mRNA synthesis raw materials by plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 20 Global mRNA synthesis raw materials by enzymes market, 2018 - 2030 (USD Million)
  • Fig. 21 Global mRNA synthesis raw materials by polymerase market, 2018 - 2030 (USD Million)
  • Fig. 22 Global mRNA synthesis raw materials by RNase inhibitor market, 2018 - 2030 (USD Million)
  • Fig. 23 Global mRNA synthesis raw materials by DNase market, 2018 - 2030 (USD Million)
  • Fig. 24 Global mRNA synthesis raw materials by others market, 2018 - 2030 (USD Million)
  • Fig. 25 Global mRNA synthesis raw materials by others market, 2018 - 2030 (USD Million)
  • Fig. 26 mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 27 mRNA synthesis raw materials market: Application market share analysis, 2023 - 2030
  • Fig. 28 Global mRNA synthesis raw materials by vaccine production market, 2018 - 2030 (USD Million)
  • Fig. 29 Global mRNA synthesis raw materials by therapeutics production market, 2018 - 2030 (USD Million)
  • Fig. 30 Global mRNA synthesis raw materials by others market, 2018 - 2030 (USD Million)
  • Fig. 31 mRNA synthesis raw materials market: End-use outlook and key takeaways
  • Fig. 32 mRNA synthesis raw materials market: End-use market share analysis, 2023 - 2030
  • Fig. 33 Global mRNA synthesis raw materials by biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 34 Global mRNA synthesis raw materials by CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 35 Global mRNA synthesis raw materials by academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Europe mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 UK mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Germany mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 France mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Italy mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Spain mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Norway mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Asia-Pacific mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Japan mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 China mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 India mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Australia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 MEA mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Key company categorization
  • Fig. 66 Company market positioning
  • Fig. 67 Market participant categorization
  • Fig. 68 Strategy framework